Autopsy report · NCT01957059
A Phase I/II Study of BMN053 in Subjects With Duchenne Muscular Dystrophy (DMD)
Cause of deathNo reason given
Life of this trial
- Ran for about 3 years 2 months before it stopped.
- 9 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1, Phase 2
- Sponsor
- BioMarin Pharmaceutical
- Sponsor type
- Industry
- Conditions
- Duchenne Muscular Dystrophy
- Interventions
- Regimen Selection Phase Group 2; Regimen Selection Phase Group 3; Treatment Phase Group 4; Regimen Selection Phase Group 1 (COMPLETED); Dosing Extension
- Participants
- 9
- Sites
- 6
- Countries
- Belgium, France, Italy, Netherlands, United Kingdom
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.